-
Views
-
Cite
Cite
Scott T. Avecilla, Chris Ferrell, Wayne L. Chandler, Morayma Reyes, Plasma-Diluted Thrombin Time to Measure Dabigatran Concentrations During Dabigatran Etexilate Therapy, American Journal of Clinical Pathology, Volume 137, Issue 4, April 2012, Pages 572–574, https://doi.org/10.1309/AJCPAU7OQM0SRPZQ
- Share Icon Share
Abstract
New anticoagulants, like the orally available direct thrombin inhibitor (DTI) dabigatran etexilate, have recently been introduced into the market for venous thromboembolic prophylaxis and for stroke prevention in atrial fibrillation. While dabigatran has been approved for use without the need for routine therapeutic monitoring, there are clinical scenarios in which monitoring can help guide clinical management. We report herein the application of a recently described plasma-diluted thrombin time (DTI assay) used to monitor intravenous DTI as a useful and easily implemented method to monitor oral DTIs.